eMedevents
  • 137102+ Medical Conferences
  • 251 Specialties
  • 10477 Organizers
  • 151771 Speakers
  • 155 Countries
  • 4555 Cities
45701+
CME Conference Registrations Sold
Home  >  Speakers  >  Ashok Srivastava
Ashok Srivastava

Ashok Srivastava

    MD, PhD, MBA
Founder, Chief | Edison, New Jersey    United States of America
Oncology
Oncology, Hematology,...More
Spoken at 1 event

Biography :

Dr. Ashok Srivastava is Chief Executive Officer and Chief Medical Officer of Cure Pharmaceuticals, and ClinFomatrix Oncology, He was founder, Chief Executive Officer and Chief Medical Officer of CareBeyond - A Radiation Therapy Cancer Center, New Jersey, USA. He has more than 15 years of experience in drug development , medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase I – 4, and marketing commercialization of Hematology, Oncology and radio-immuno-oncology drugs in USA , EU and Japan.

He is leader in Cancer Drug Development Worldwide large and complex Phase 3 Clinical Trials. He contributed to 21-INDs and 7-NDAs of Cancer Drugs, acquisition /merger of company and drug for more than $300 million. He received his clinical, medical training & worked at renowned medical centers and pharmaceutical institutions worldwide; Walter Reed Army Institute of Research and Medical Center, Daiichi, Sumitomo, Pharmacia, Pfizer, Eisai Oncology, and Spectrum Pharmaceuticals.

**********************
************* ************* ************
 
For speaker's contact information - Contact us

Specialties

Oncology

Interested Topics

Oncology, Hematology, Ophthalmology, Psychiatry, Drug Safety, Pharmacovigilance, Regulatory Affairs, Data Management, Biostatistics, Hematologic Tumors, Chemotherapy, Hematologic Malignancies, Palliative Care

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English, Japanese

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message